[
  {
    "ts": "2025-12-28T07:17:11+00:00",
    "headline": "Zoetis (ZTS) Positioned Within Morgan Stanley’s 2026 Healthcare Playbook",
    "summary": "Zoetis Inc. (NYSE:ZTS) is included among the 15 Dividend Stocks with Low Payout Ratios and Strong Upside. On December 18, Morgan Stanley lowered its price target on Zoetis Inc. (NYSE:ZTS) to $160 from $175 and kept an Overweight rating. In its year-ahead outlook, the firm said healthcare technology and providers offer an “attractive backdrop for […]",
    "url": "https://finance.yahoo.com/news/zoetis-zts-positioned-within-morgan-071711851.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "718f79d4-7986-3bb5-9825-70e03bfea42c",
      "content": {
        "id": "718f79d4-7986-3bb5-9825-70e03bfea42c",
        "contentType": "STORY",
        "title": "Zoetis (ZTS) Positioned Within Morgan Stanley’s 2026 Healthcare Playbook",
        "description": "",
        "summary": "Zoetis Inc. (NYSE:ZTS) is included among the 15 Dividend Stocks with Low Payout Ratios and Strong Upside. On December 18, Morgan Stanley lowered its price target on Zoetis Inc. (NYSE:ZTS) to $160 from $175 and kept an Overweight rating. In its year-ahead outlook, the firm said healthcare technology and providers offer an “attractive backdrop for […]",
        "pubDate": "2025-12-28T07:17:11Z",
        "displayTime": "2025-12-28T07:17:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/b655809e72771ce502a6041d7150bbcb",
          "originalWidth": 1000,
          "originalHeight": 682,
          "caption": "Zoetis (ZTS) Positioned Within Morgan Stanley’s 2026 Healthcare Playbook",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gnDFgHeAuMGRZnq2EyJs4A--~B/aD02ODI7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/b655809e72771ce502a6041d7150bbcb.cf.webp",
              "width": 1000,
              "height": 682,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qe41aidP5v9ZqEAoy2.wwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/b655809e72771ce502a6041d7150bbcb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-zts-positioned-within-morgan-071711851.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-zts-positioned-within-morgan-071711851.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]